| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Apr 28, 2010
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that its Board of Directors declared a quarterly dividend of $0.0625 per share, payable on June 15, 2010 to shareholders of record on May...
-
Apr 16, 2010
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it will release financial results for its third quarter fiscal 2010 on Thursday, April 29, 2010 at approximately 8:00 a.m. (ET). The...
-
Apr 15, 2010
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has been named as an authorized generic partner by Ferndale Laboratories and has launched an authorized generic of Analpram HC®...
-
Apr 13, 2010
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) and Graceway Pharmaceuticals, LLC., (based in Bristol, TN) today announced that they have entered into an agreement to settle all existing patent...
-
Apr 8, 2010
Perrigo Company of South Carolina, Inc. (NASDAQ: PRGO)(TASE: PRGO) announced today that it won two favorable jury verdicts against Rexall Sundown, Inc. in an unfair competition lawsuit that was...
-
Apr 5, 2010
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that, together with its partner Cobrek Pharmaceuticals, Inc., it has agreed to settle all Hatch-Waxman litigation relating to...
-
Apr 5, 2010
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that together with its partner Cobrek Pharmaceuticals, Inc. final approval has been received from the U.S. Food and Drug Administration...
-
Mar 23, 2010
-- PBM Holdings is the world's largest manufacturer and marketer of infant formulas for the store brand market -- All cash transaction with a purchase price of $808 million -- Acquisition expected...
-
Mar 15, 2010
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has begun shipping Ketotifen Fumarate ophthalmic solution, 0.025%, a generic version of Zaditor™. Zaditor™ is a sterile...
-
Mar 1, 2010
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has signed a definitive purchase agreement to acquire Orion Laboratories Pty, Ltd. for approximately $48 million in cash. Based...
-
Feb 18, 2010
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has received final approval from the U.S. Food and Drug Administration to manufacture and market Ciclopirox Shampoo, 1%, a...
-
Feb 12, 2010
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that a federal court has granted summary judgment in its favor in patent litigation involving Guaifenesin Extended-Release Tablets, 600...
-
Feb 2, 2010
-- Fiscal second quarter revenue from continuing operations increased $46 million, or 9%, to $583 million -- Fiscal second quarter adjusted income from continuing operations increased 56% to $65...
-
Jan 27, 2010
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that its Board of Directors declared a quarterly dividend of $0.0625 per share, payable on March 16, 2010 to shareholders of record on...
-
Jan 19, 2010
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it will release financial results for its second quarter fiscal 2010 on Tuesday, February 2, 2010 at approximately 8:00 a.m. (ET)....
-
Jan 7, 2010
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that Perrigo Chairman and CEO Joseph C. Papa will present at the 28th Annual J.P. Morgan Healthcare Conference on Monday, January 11, at...
-
Dec 9, 2009
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has filed an Abbreviated New Drug Application for Clobetasol Propionate Topical Spray, 0.05%, a generic form of Clobex® Spray....
-
Dec 7, 2009Gluten-free labeling program an industry first for over-the-counter pharmaceuticals
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced it will implement a labeling program to help consumers more clearly identify more than 200 of the company's over-the-counter store-brand...
-
Nov 19, 2009
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that Perrigo Chairman and CEO Joseph C. Papa will present at the Sidoti Emerging Growth Conference on Friday, November 20, at 3:15 p.m....
-
Nov 9, 2009In the news release, Perrigo Company to Present at the Credit Suisse 18th Annual Health Care Conference, issued 09-Nov-2009 by Perrigo Company over PR Newswire, we are advised by the company that in the first paragraph, the conference date and time should
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that Perrigo Chairman and CEO Joseph C. Papa will present at the Credit Suisse 18th Annual Health Care Conference on Wednesday, November...
-
Nov 9, 2009
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that Perrigo Chairman and CEO Joseph C. Papa will present at the Credit Suisse 18th Annual Health Care Conference on Wednesday, November...
-
Nov 2, 2009
-- Fiscal first quarter revenue from continuing operations increased $72 million, or 16%, to $528 million -- Fiscal first quarter GAAP income from continuing operations increased 59% to $61...
-
Nov 2, 2009
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has signed a definitive agreement to sell its Israel Consumer Products business along with the related production assets in...
-
Oct 29, 2009
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that its Board of Directors declared a quarterly dividend of $0.0625 per share, payable on December 15, 2009 to shareholders of record on...
-
Oct 19, 2009
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it will release financial results for its first quarter fiscal 2010 on Monday, November 2, 2009 at approximately 8:00 a.m. (ET). The...